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Genetic and cell-based studies have implicated the
PAF1 complex (PAF1C) in transcription-associated
events, but there has been no evidence showing a
direct role in facilitating transcriptionof a natural chro-
matin template. Here, we demonstrate an intrinsic
abilityofhumanPAF1C (hPAF1C) to facilitateactivator
(p53)- and histone acetyltransferase (p300)-depen-
dent transcription elongation from a recombinant
chromatin template in a biochemically defined RNA
polymerase II transcription system. This represents
a PAF1C function distinct from its established role in
histone ubiquitylation and methylation. Importantly,
we further demonstrate a strong synergy between
hPAF1Candelongation factor SII/TFIIS and an under-
lying mechanism involving direct hPAF1C-SII interac-
tions and cooperative binding to RNA polymerase II.
Apart from a distinct PAF1C function, the present
observations provide a molecular mechanism for the
cooperative function of distinct transcription elonga-
tion factors in chromatin transcription.
INTRODUCTION
RNA polymerase II (Pol II)-mediated transcription is a highly
coordinated processwith threemajor steps (initiation, elongation
and termination) that normally occur in the context of nucleo-
somal arrays within chromatin. Whereas nucleosomesmay exert
an inhibitory effect on transcription initiation, reflecting a block in
preinitiation complex (PIC) formation (Knezetic and Luse 1986;
Lorch et al., 1987; Workman and Roeder 1987), they also serve
as a barrier to elongating Pol II complexes both in vitro (Bondar-
enko et al., 2006; Guermah et al., 2006) and in vivo (Han and
Grunstein, 1988). During elongation in living cells, specific Pol
II-associated factors help Pol II to overcome pausing resulting
from specific DNA sequences, bound proteins or nucleosome
structures (Li et al., 2007).
Genetic and biochemical approaches have identified several
Pol II-associated transcription elongation factors that include
SII/TFIIS, TFIIF, DSIF, Elongin, ELL, NELF, the PAF1 complex(PAF1C) and the histone chaperone FACT (Sims et al., 2004).
Although transcription defects resulting from mutations in these
factors are consistent with intracellular functions in transcription
elongation, only a few such as SII (Kireeva et al., 2005; Guermah
et al., 2006) and FACT (Orphanides et al., 1998) have actually
been shown to have intrinsic transcription elongation activities
on natural (chromatin) templates; and detailed mechanisms of
action of many of these factors are just beginning to be under-
stood (Sims et al., 2004). In addition, the presence of multiple
elongation factors in eukaryotic cells suggests a potential for
cooperative, as well as redundant, functions in chromatin
transcription. In accordance with this, recent experiments have
revealed genetic and physical interactions between distinct
elongation factors (Arndt and Kane, 2003). However, there has
been no direct biochemical evidence for cooperative functions
in chromatin transcription.
PAF1C was originally identified in yeast as a Pol II-associated
factor (Shi et al., 1996) comprised of the Ctr9, Leo1, Rtf1, Paf1
and Cdc73 subunits (Mueller and Jaehning, 2002). PAF1C is of
special interest because it has been implicated in transcription
elongation (Costa and Arndt, 2000; Betz et al., 2002; Squazzo
et al., 2002; Rondon et al., 2004) and, potentially related, is
required for H2B ubiquitylation and downstream H3K4 and
H3K79 methylation both in yeast (Ng et al., 2003; Krogan et al.,
2003; Wood et al., 2003) and in human (Zhu et al., 2005; Kim
et al., 2009). However, there has been no direct biochemical
evidence for a role in transcription elongation on chromatin
templates independent of its role in histone modifications.
Beyond demonstrated and presumed roles for PAF1C in histone
modification and transcription elongation, respectively, genetic
and biochemical studies in yeast have suggested PAF1C func-
tions in other gene expression processes that include transcript
site selection (Stolinski et al., 1997; Mueller and Jaehning, 2002)
and mRNA processing steps that couple transcriptional and
posttranscriptional events (Mueller et al., 2004; Sheldon et al.,
2005; Rozenblatt-Rosen et al., 2009). Further emphasizing the
importance of PAF1C in diverse cellular processes, but by as
yet unknown mechanisms, recent studies in metazoans have
identified PAF1C subunits as candidate oncogenes and tumor
suppressors (Chaudhary et al., 2007) and established functions
both in embryonic development and cell survival (Mosimann
et al., 2006; Wang et al., 2008) and in the maintenance of ES
cell identity (Ding et al., 2009).Cell 140, 491–503, February 19, 2010 ª2010 Elsevier Inc. 491
Figure 1. Characterization of Native and Reconstituted hPAF1Cs
(A) Silver staining and immunoblots of native hPAF1C purified from the FLAG-hPAF1 HeLa cell line. Non-specific proteins (marked by asterisks) are thought to be
Hsp70, tubulin and actin (cf. Zhu et al., 2005). The indicated hRTF1 polypeptide is close in size to that encoded by residues 157-585 of the long hRTF1 open
reading frame (Figure S1).
(B) Immunoblots of purified native hPAF1C following Superose 6 gel filtration. Note that hRTF1 peaked separately from the circa 670 kDa complex and formed
a stable trimeric complex with hPAF1 and hCDC73 through its C terminus (Figure S1).
(C) Coomassie blue staining and immunoblots of the purified, baculovirus-reconstituted hPAF1C.
(D) Immunoblots of purified baculovirus-reconstituted hPAF1C following Superose 6 gel filtration.
(E) Multivalent hPAF1C subunit interactions. Arrows indicate direct interactions based on the analyses in Figure S2, with a weak interaction depicted by the
dashed arrow.Here, we show that the human PAF1 complex (hPAF1C)
exhibits not only an intrinsic transcription elongation activity
that facilitates activator- and histone acetyltransferase-depen-
dent transcription from a chromatin template but also, and
perhaps more importantly, a strong cooperative function with
SII. We also demonstrate a direct hPAF1C-Pol II interaction
that is important for the intrinsic transcription activity of hPAF1C,
as well as a direct interaction between hPAF1C and SII that
results in cooperative binding to Pol II and is required for their
synergistic function. These findings identify distinct hPAF1C
functions and provide biochemical evidence for cooperative
functions between distinct transcription elongation factors in
activator-dependent transcription from chromatin templates.
RESULTS
Composition and Structural Organization of hPAF1C
Human PAF1C was affinity purified from a FLAG-hPAF1 HeLa
cell line and found to contain homologs (hCTR9, hLEO1,
hPAF1, hCDC73 and hRTF1) of the five yeast PAF1C subunits,
as well as the SKI8 subunit unique to hPAF1C (Figure 1A). How-
ever, consistent with earlier reports of human and Drosophila
PAF1Cs lacking RFT1 (Rozenblatt-Rosen et al., 2005; Yart492 Cell 140, 491–503, February 19, 2010 ª2010 Elsevier Inc.et al., 2005; Zhu et al., 2005; Adelman et al., 2006), hRTF1 was
at least partially dissociated from the native hPAF1C upon gel
filtration (Figure 1B). Consistent with our demonstration of a
six-subunit complex in HeLa cells, we were able to reconstitute
and affinity purify a similar complex, containing stoichiometric
amounts of all six subunits, from Sf9 cells coinfected with bacu-
loviruses that individually express the various subunits (Figures
1C and 1D). Given the pivotal role of the RTF1 subunit in
PAF1C function in many organisms (Mueller and Jaehning,
2002; Ng et al., 2003; Adelman et al., 2006; Tenney et al.,
2006; Warner et al., 2007; Ding et al., 2009), it is of interest that
HeLa cells were found to contain several forms of hRTF1 that
potentially arise from alternative splicing (Figure S1).
Taking advantage of the ability to selectively express recombi-
nant hPAF1C subunits in insect cells, we determined the effect of
individual subunit deletions on complex formation as well as
direct interactions between pairs of coexpressed subunits. The
results (detailed in Figure S2) led to establishment of the interac-
tion network shown in Figure 1E. It is noteworthy, for functional
and mechanistic studies described in later sections, that the
extensive interaction network allows the reconstitution and isola-
tion of complexes that effectively lack only one or two subunits.
hPAF1 appears to be the key scaffold subunit since omission of
Figure 2. Synergistic Effect of hPAF1C and SII on p53-Dependent
Chromatin Transcription
(A) Schematic representation of the standard in vitro transcription assay.
Transcription factors included TFIID, TFIIA, TFIIB, TFIIE, TFIIF, TFIIH, PC4,
Mediator, and Pol II. Chromatin-based assays also contained the components
(ACF1, ISWI, and NAP1) employed for chromatin assembly.
(B) Independent and cooperative effects (with SII) of reconstituted hPAF1C on
chromatin transcription. Reactions contained p300/acetyl-CoA (all lanes) and,
as indicated, 10 ng p53, 10 ng SII and either 160 ng (lanes 3 and 8), 320 ng
(lanes 4 and 9) or 640 ng (lanes 5 and 10) of reconstituted hPAF1C.
(C) Independent and cooperative effects (with SII) of native hPAF1C on
chromatin transcription. Reactions contained p53 and p300/acetyl-CoA
(all lanes) and, as indicated, 10 ng SII and either 17.5 ng (lanes 2 and 6),
35 ng (lanes 3 and 7) or 70 ng (lanes 4 and 8) of native hPAF1C or 70 ng (lanes 9
and 10) of reconstituted hPAF1C.any other subunit in the reconstitution of complexes purified
through coexpressed FLAG-hPAF1 results in complexes lacking
only that subunit (with the exception of concomitant hSKI8 loss
when hCTR9 is deleted), whereas deletion of hPAF1 in the recon-
stitution of complexes purified through FLAG-hCTR9 or FLAG-
hRTF1 may result in significantly diminished levels of an addi-
tional subunit (e.g., hLEO1 in the FLAG-hCTR9 complex and
hCTR9 in the FLAG-hRTF1 complex; Figure S2). These results
are consistent with genetic analyses in yeast indicating selective
loss of PAF1C functions upon deletions of individual subunits
(Mueller et al., 2004; Porter et al., 2005; Xiao et al., 2005), and
also indicate that individual binary interactions are reinforced
by more global cooperative interactions within hPAF1C.
An Intrinsic Effect of hPAF1C, as Well as a Synergistic
Effect with SII, on p53- and p300-dependent
Transcription from Chromatin Templates
In order to test for and to establish direct functions of transcrip-
tion elongation factors on natural (chromatin) templates, we
employed an in vitro transcription assay (schematized in Fig-
ure 2A) containing highly purified transcription factors (Pol II,
TFIID, TFIIA, TFIIB, TFIIE, TFIIF, TFIIH, PC4, and Mediator) and
a chromatinized pML array template that contains p53-binding
sites adjacent to a core promoter and generates 390-nucleotide
transcription products. This system previously was shown to
effect activator-dependent transcription both from a naked
DNA template and, in conjunction with p300 and SII, from a
chromatin template (Guermah et al., 2006).
Importantly, in testing for a possible effect of hPAF1C on p53-
and p300-dependent transcription from a chromatin template,
we observed dose-dependent stimulatory effects of both recon-
stituted (Figure 2B, lanes 7–10) and native (Figure 2C, lanes 1–4)
hPAF1Cs, thus demonstrating an intrinsic ability of hPAF1C to
enhance transcription from a chromatin template. Further anal-
yses revealed that the hPAF1C effect is completely dependent
upon p53 and p300/acetyl-CoA (Figure 2D) and cannot be over-
come by saturating amounts of p300/acetyl-CoA (Figure S3A).
These results establish non-redundant functions between p300
and hPAF1C.
The presence in living cells of multiple factors implicated in
transcription elongation raises the possibility of their cooperative
functions, as well as redundancies, in transcription. Having
both a purified hPAF1C with recognized transcription activity(D) p53- and p300/acetyl-CoA- dependent function of hPAF1C. Reactions
contained 10 ng p53, 15 ng p300 and 320 ng baculovirus-reconstituted
hPAF1C, as indicated, but no SII.
(E) Independent and cooperative effects (with SII) of hPAF1C in NFkB(p65)-
dependent chromatin transcription. Reactions contained chromatin assem-
bled with pG5ML plasmid, 10 ng Gal4-p65 and p300/acetyl-CoA (all lanes)
and, as indicated, 10 ng SII and 280 ng reconstituted hPAF1C.
(F) Titration of hPAF1C and SII in an in vitro chromatin transcription assay.
Reactions contained p53 and p300/acetyl-CoA (all lanes) and, as indicated,
either 5 ng (lanes 5–8), 10 ng (lanes 9–12) or 20 ng (lanes 13–16) of SII and
either 70 ng (lanes 2, 6, 10 and 14), 140 ng (lanes 3, 7, 11, and 15) or 280 ng
(lanes 4, 8, 12, and 16) of reconstituted hPAF1C. In (B), (C), (E) and (F), relative
transcription levels were quantitated by phosphoimager and normalized to
that of 10 ng SII alone. As shown in Figure S3, the effects of hPAF1C on tran-
scription were still observed under saturating levels of Mediator and p300.
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on chromatin template and SII with its previously established
function in transcription elongation (Guermah et al., 2006), we
tested the possibility of synergism between these factors.
Remarkably, the p53-dependent transcription activity observed
with SII (in the presence of p300) was significantly enhanced
by the reconstituted hPAF1C in a dose-dependent manner (Fig-
ure 2B, lanes 2–4), with the synergistic effect being saturated at
the highest tested dose of hPAF1C (lane 5). The native hPAF1C
also showed a comparable, albeit slightly lower, level of
enhanced transcription relative to that obtained with the recon-
stituted hPAF1C (Figure 2C, compare lanes 8 and 10). However,
the lower synergistic effect with the native complex relative to the
reconstituted complex may simply reflect our inability to assay a
comparable amount of native hPAF1C owing to its more dilute
concentration. Of note, while the present study has focused on
transcription events in response to p53, our demonstration of
similar independent and cooperative hPAF1C functions in
NFkB(p65)-dependent transcription (Figure 2E) suggests that
these functions will be broadly applicable to other activators.
In our purified transcription system, all general transcription
factor preparations were titrated to determine the amounts
that gave optimal activity. As an example of the verification of
saturating levels of a factor, a two-fold increase in the normal
Mediator concentration had no effect on the overall synergy
between SII and hPAF1C (Figure S3B). This rules out the possi-
bility that hPAF1C or SII is simply substituting for a limiting
amount of a general transcription factor in the assay. In more
detailed titrations of SII and hPAF1C (Figure 2F), hPAF1C, in a
dose-dependent manner, markedly increased transcription at
lower levels of SII (lanes 5–12) but only moderately increased
transcription at the highest level of SII where the SII-dependent
activity was higher (lanes 13–16). This is consistent with a mech-
anism, also supported by protein interaction studies (below), in
which hPAF1C facilitates SII binding to Pol II for its subsequent
(previously established) function in Pol II passage through nucle-
osomes.
Direct Evidence for Transcription Elongation Activities
of hPAF1C and SII on a Chromatin Template
The results described thus far have not clearly addressed
whether hPAF1C acts, either alone or synergistically with SII,
during preinitiation complex (PIC) formation or during transcrip-
tion elongation. To address this issue, we first assembled a
complete PIC on a DNA template in the presence of p53 and
purified transcription factors and then performed sequential
chromatin assembly, p300-dependent histone acetylation, and
transcription steps (Figure 3A). The results show that p300/
acetyl-CoA and hPAF1C are both required at a step after PIC
assembly for optimal activity in the absence of SII (Figure 3B,
lane 4 versus lanes 2 and 3) and, similarly, that p300/acetyl-
CoA and SII are both required at a step after PIC assembly for
transcription in the absence of hPAF1C (lane 6 versus lanes 3
and 5). In addition, hPAF1C also exhibited strong synergy with
SII in this assay (lane 7 versus lanes 4 and 6), thus suggesting
that hPAF1C and SII work cooperatively at a postinitiation step.
To rule out the possibility in this analysis that hPAF1C or SII
simply stabilizes and/or activates the PIC, even though they
are added after PIC formation, and to provide more direct494 Cell 140, 491–503, February 19, 2010 ª2010 Elsevier Inc.evidence for hPAF1C and SII function at the transcription elonga-
tion stage, we designed a new transcription elongation assay
(Figure 3C) based on a combination and modification of earlier
protocols (Izban and Luse, 1992; Renner et al., 2001; Ujva´ri
and Luse, 2006). Since the generation of transcripts with at least
21-nuleotides is not strictly dependent upon transcription elon-
gation factors in our chromatin-templated assay (Guermah
et al., 2006), a short (17-nucleotide) radiolabeled transcript was
first synthesized from the p53ML-17 chromatin template and,
after purification of the early elongation complex, transcription
then was allowed to proceed in the presence and in the absence
of transcription elongation factors (Figure 3C, see Extended
Experimental Procedures for details). Importantly, this proce-
dure includes two critical purification steps that validate this
assay. The first is gel filtration of assembled chromatin to remove
free ATP and thus restrict synthesis in the next step to the short
radiolabeled CpA-primed transcript. The second is gel filtration
to separate the early elongation complex on the chromatin
template from residual radiolabeled nucleotides so that all visu-
alized elongating transcripts originate from preexisting radiola-
beled short transcripts. The results show that SII (Figure 3D,
lanes 5–7 versus lanes 2–4) and hPAF1C (lanes 8-10 versus lanes
2-4) can independently facilitate transcription elongation in
a time-dependent manner. Remarkably, SII and hPAF1C also
exhibited strong synergy in this assay (lanes 11–13 versus lanes
5–7 and lanes 8–10), with themost obvious effects at the shortest
elongation times (lane 11 versus lanes 5 and 8). These data
demonstrate unequivocally that hPAF1C has an intrinsic tran-
scription activity and that it acts cooperatively with SII at a tran-
scription elongation stage.
Direct Interactions of hPAF1C with Pol II and SII
Are Required for Its Intrinsic and Synergistic Effects
on Chromatin Transcription
To examine the role of individual PAF1C subunits in hPAF1C
interactions and functions, and to relate functions to specific
interactions, several different hPAF1 sub-complexes (containing
FLAG-hCTR9) were reconstituted in insect cells and subse-
quently purified (Figure S4). Consistent with the hPAF1C subunit
interaction network and the role of hPAF1 as a scaffold protein
(above), purified complexes reconstituted in the absence of
hLEO1, hPAF1, hRTF1, or both hLEO1 and hPAF1 lacked mainly
these subunits but were recovered in lower amounts in the case
of the hPAF1-deficient complexes (Figure S4).
Relevant to the mechanism underlying the intrinsic hPAF1C
activity, and consistent with the original isolation of the yeast
PAF1 complex in association with Pol II (Shi et al., 1996), purified
hPAF1C was found to interact directly with purified Pol II (Fig-
ure 4A). Interestingly, whereas the hLEO1-deficient hPAF1C in-
teracted normally with Pol II, hPAF1C lacking hPAF1 showed a
significantly decreased binding compared to the intact complex
and hPAF1Cmissing both hLEO1 and hPAF1 showed no detect-
able binding. These findings are consistent with the results of
binding assays with individual purified hPAF1C subunits (Fig-
ure S4), which revealed that hPAF1 interacts strongly, and
hLEO1 weakly, with endogenous Pol II (Figure 4B). In functional
analyses, purified reconstituted complexes lacking either hLEO1
or hPAF1 showed only modest reductions in activity compared
Figure 3. hPAF1C Independently and Cooperatively with SII Stimulates Transcription Elongation
(A) Schematic representation of the in vitro transcription assay in (B).
(B) Independent and cooperative hPAF1C and SII functions after PIC assembly. Preinitiation complexes were formed prior to chromatin assembly by incubation
of DNAwith p53 and transcription factors. After subsequent chromatin assembly, sequential incubations with p300/acetyl-CoA, hPAF1C (320 ng), and SII (10 ng),
as indicated, were carried out. Relative transcription levels were quantitated by phosphoimager and normalized to that of SII alone.
(C) Schematic representation of the in vitro transcription elongation assay in (D).
(D) Independent and cooperative hPAF1C and SII functions at the transcription elongation stage. Radiolabeled, chromatin-associated early elongation
complexes were prepared according to the protocol in (C) and allowed to elongate in the presence of hPAF1C (320 ng) and/or SII (30 ng) as indicated.to the intact complex (Figure 4C, lanes 2-4) whereas the complex
missing both hLEO1 and hPAF1was completely inactive (lane 5).
These results establish hPAF1 and hLEO1 functions, apparently
partly redundant, in the intrinsic transcription activity of hPAF1C
and further suggest that intact hPAF1C normally functions in this
capacity mainly through a direct hPAF1-mediated interaction
with Pol II.
Relevant to themechanism underlying the observed functional
synergy between hPAF1C and SII, purified hPAF1C showed a
strong, direct interaction with a purified GST-SII fusion protein
but not with GST (Figure 4D). Moreover, in a test for intracellular
interactions, endogenous hPAF1C subunits were coimmunopre-cipitated either with endogenous SII using an anti-SII antibody
(Figure 4E) or with ectopically expressed FLAG-SII using M2
agarose (data not shown). These observations indicate that
hPAF1C directly interacts with SII both in vitro and in vivo. In
further analyses with individual purified hPAF1C subunits (Fig-
ure S4), hLEO1 and hPAF1, but not other subunits, were shown
to interact directly and strongly with SII (Figure 4F). The hLEO1-
and hPAF1-deficient complexes, but not the complex lacking
both hLEO1 and hPAF1, retained the ability to bind to immobi-
lized SII, in further support of roles for both hLEO1 and hPAF1
in hPAF1C-SII interaction (Figure 4G). Of note, since the isolated
hPAF1 and hLEO1 subunits both bind strongly to SII, the lowerCell 140, 491–503, February 19, 2010 ª2010 Elsevier Inc. 495
Figure 4. Direct Physical and Functional Interactions of hPAF1C with Pol II and SII
(A and B) Binding to Pol II of (A) purified hPAF1Cs that lack indicated subunits (Figure S4C) or (B) purified hPAF1C subunits (Figure S4B).
(C) Chromatin transcription with SII and indicated hPAF1Cs. SII (10 ng) and reconstituted hPAF1Cs (320 ng for intact complex) containing equivalent amounts of
FLAG-hCTR9 were assayed as indicated. p53 and p300/acetyl-CoA were added to all reactions.
(D, F, and G) Binding of (D) purified hPAF1C (Figure 1C), (F) purified hPAF1C subunits (Figure S4B) or (G) purified hPAF1Cs that lack indicated subunits
(Figure S4C) to purified GST versus GST-SII (Figure S4A). (E) Intracellular binding of hPAF1C to SII. HeLa nuclear extracts were immunoprecipitated with
anti-SII antibody and bound proteins were visualized by immunoblots with indicated antibodies (hRTF1 and hCDC73 are not shown because of their comigration
with IgG heavy chain).level of binding of the hPAF1-deficent complex relative to that of
the hLEO1-deficent complex appears to reflect a lower level of
retained hLEO1 in the hPAF1-deficent complex (Figure S4).
In functional studies, the FLAG-hCTR9-derived hPAF1C, like
the FLAG-hPAF1-derived hPAF1C, also showed a significant
synergistic effect with SII in chromatin-templated transcription
(Figure 4C, lane 8 versus lanes 2 and 7). Exclusion of either
hLEO1 or hPAF1 led to about a 50% reduction in activity
compared to that of the intact hPAF1C (lanes 9 and 10 versus
lane 8), whereas the simultaneous omission of hPAF1 and
hLEO1 reduced the transcription level to that observed with SII496 Cell 140, 491–503, February 19, 2010 ª2010 Elsevier Inc.alone (lane 11 versus lane 7). Along with the binding data, these
results clearly indicate that the synergistic effect of SII and
hPAF1C is achieved by their physical interaction through the
hLEO1 and hPAF1 subunits in hPAF1C. It is important to note,
however, that the reduced transcriptional synergy of the hLEO1-
deficient complex with SII (Figure 4C) contrasts with the normal
strong interaction of this complex with SII (Figure 4G). This
suggests, as shown below (Figure 5), that hLEO1 has a role in
transcriptional synergy beyond the direct interaction with SII.
Also of note, omission of hRTF1 from hPAF1C led only to a very
modest decrease in the synergistic effect (Figure 4C, lane 12),
Figure 5. Cooperative Binding of hPAF1C and SII to Pol II
Binding of purified SII and hPAF1C to Pol II. HeLa nuclear extracts (A) or puri-
fied Pol II (B and C) were incubated with GST-SII or reconstituted hPAF1Cs
(containing FLAG-hCTR9) in the presence and in the absence, respectively,
of purified reconstituted hPAF1Cs or SII as indicated. hPAF1Cs in (C) were
reconstituted with subunit omissions as indicated.suggesting that hRTF1 is not a critical component for the syner-
gistic function with SII but leaving open the possibility that it
may contribute to other functions of hPAF1C (see Discussion).
Cooperative Binding of hPAF1C and SII to RNA
Polymerase II
To elucidate the mechanism(s) underlying the synergism
between hPAF1C and SII in chromatin transcription, we tested
the possibility of cooperative binding of these factors to Pol II.
As expected, endogenous Pol II in nuclear extract bound selec-
tively to immobilized GST-SII relative to GST alone, but this
binding was significantly enhanced by addition of purified
hPAF1C (Figure 5A, lanes 1–5). Reciprocally, endogenous Pol
II in nuclear extract bound selectively to an M2 agarose-immobi-
lized (FLAG-hCTR9) hPAF1C relative to M2 agarose alone, and
purified SII markedly enhanced this interaction (lanes 6–10). A
similar analysis with purified Pol II revealed hPAF1C-mediated
enhancement of Pol II binding to immobilized GST-SII relative
to GST alone, indicating that the cooperative binding of hPAF1C
and SII to Pol II is mediated by direct protein-protein interactions
(Figure 5B).Next, we tested whether the observed direct interaction
between hPAF1C and SII is required for their cooperative binding
to Pol II (Figure 5C). The strong hPAF1C-dependent binding of
Pol II to SII (lane 4 versus lane 3) was greatly reduced by deletion
of hLEO1 from hPAF1C (lane 6), more drastically reduced by
deletion of hPAF1 (lane 7), and almost completely abolished by
deletion of hPAF1 and hLEO1 (lane 5). In contrast, deletion of
hRTF1 had no significant effect on the cooperative interactions
(lane 8). It is important to note that whereas hLEO1 is required
for the cooperative binding of hPAF1C and SII to Pol II, it is not
required for the strong independent binding of hPAF1C to SII
(Figure 4G). These results suggest that hLEO1 plays an espe-
cially important role, through its direct SII interaction, in the
cooperative binding of hPAF1C and SII to Pol II. The fact that
a solitary hLEO1 deletion has no effect on the SII-independent
interaction of hPAF1C with Pol II (Figure 4A) and only a modest
effect on the intrinsic hPAF1C transcription activity (Figure 4C)
also argues both for a hLEO1-selective function and for the
structural integrity of the hLEO1-deficient hPAF1C. Overall,
these effects of hLEO1 and/or hPAF1 deletion on cooperative
binding of hPAF1C and SII to Pol II correlate well with effects
of the deletions on the functional synergy between hPAF1C
and SII (Figure 4C), thus suggesting a causal relationship.
Recruitment of hPAF1C and SII to Endogenous
Genes during Transcriptional Activation
In order to investigate in vivo functions of hPAF1C and SII during
gene activation, the p53-dependent doxorubicin-inducible p21
gene (Figure 6A) was subjected to comprehensive chromatin
immunoprecipitation (ChIP) analyses using the amplicons sum-
marized in Figure 6B. In agreement with past studies (Gomes
et al., 2007), we observed (1) a basal level of p53 occupancy at
p53 response elements (regions labeled ‘‘A’’ and ‘‘B’’ in Fig-
ure 6B) followed by doxorubicin-induced increases in p53 occu-
pancy at these sites (Figure 6C), (2) a significant basal level of Pol
II (RPB1) occupancy at the promoter region (C) followed by
doxorubicin-induced increases in Pol II occupancy both at the
promoter (C) and along the coding regions (D, E, F) (Figure 6C),
and (3) doxorubicin-induced accumulation of histone modifica-
tions (acetylated and K4-methylated H3) associated with gene
activation (Figure S5).
The SII occupancy pattern was similar to that observed for Pol
II, implying that recruitment of SII to the chromatin is mainly
dependent on Pol II, but with the exception that SII occupancy
peaks at 6 hr whereas Pol II occupancy continues to increase
to at least 12 hr (Figure 6C). ChIP analyses for several hPAF1C
subunits showed patterns somewhat similar to that observed
for SII, but with the following differences from SII and/or Pol II.
First, association of hPAF1C subunits with chromatin showed
time-dependent increases (up to 12 hr) following induction at
promoter and coding regions. Second, occupancy at the
promoter region (C) was not significant at the uninduced (0 h)
stage, in contrast to the significant basal level occupancy by
Pol II and SII, suggesting that recruitment of hPAF1C to the
promoter region is tightly regulated by on-going transcription.
Third, hPAF1C subunits showed higher levels of accumulation
at coding regions (D, E, F) relative to the promoter region (C)
than did SII, suggesting non-identical (but overlapping)Cell 140, 491–503, February 19, 2010 ª2010 Elsevier Inc. 497
Figure 6. Distribution of hPAF1C and SII on the p21 Locus during p53-Dependent Transcription
(A) Doxorubicin induction of p53 and the p21 target gene. HCT116 cells were treatedwith 0.5 mMdoxorubicin for the indicated times, and protein andmRNA levels
were analyzed by immunoblot and RT-PCR, respectively.
(B) Schematic representation of the p21 locus indicating the six amplicons used for real-time PCR.
(C) ChIP analyses on the p21 locus. Cells were treated as in (A) and ChIP analyses were performed with indicated antibodies. Error bars denote standard
deviations from three independent PCR reactions from a single ChIP that is representative of several that were performed.
(D–F) HCT116 cells were treated with control and hPAF1-targeted siRNAs as indicated. Cell extracts were analyzed by immunoblots with indicated antibodies (D).
p21 mRNA levels were measured by quantitative PCR analysis and normalized to GAPDH mRNA. Error bars represent standard deviations from three indepen-
dent PCR reactions (E). (F) After siRNA transfection, cells were treated with doxorubicin as in (A) and ChIP analyses were performed as in (C). (Note that the data
in [C] are part of a comprehensive ChIP analysis and limited parts [e.g., p53 and p21 expression data and p53 and Pol II ChIP data] were recently published
(Kim et al., 2009), for cross reference, with more extensive data on ubiquitylated H2B and H2B ubiquitylation factor analyses.) Additional data presented in
Figure S5 document corresponding increases in H3 acetylation and H3K4 methylation on the p21 locus during induction by doxorubicin.
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Figure 7. Models of Independent and Cooperative
Functions of hPAF1C and SII in Transcription
Elongation
Human PAF1C and SII independently facilitate transcrip-
tion elongation through direct interactions with Pol II. In
the case of hPAF1C, this involves a strong hPAF1-Pol II
interaction (solid arrow) and a weak hLEO1-Pol II interac-
tion (dashed arrow). While not shown, cooperative inter-
subunit interactions within hPAF1C potentiate its interac-
tion with Pol II relative to the independent interactions of
individual subunits with Pol II. A direct interaction between
SII and hPAF1C (via hPAF1 and hLEO1) results in their
cooperative binding to Pol II (depicted by thick arrows)
and a strong synergistic effect on transcription elongation.mechanisms/roles for hPAF1C and SII in the transcription elon-
gation process (see Discussion). Remarkably, hRTF1 showed
a pattern of accumulation indistinguishable from those of other
hPAF1C components, strongly indicating a role for hRTF1 in
conjunction with other hPAF1C subunits.
Given the observed cooperative interaction of hPAF1C and SII
with Pol II, we tested whether the distribution of SII on the active
p21 gene is dependent upon or modulated by hPAF1C. hPAF1
siRNA, but not a control siRNA, resulted in a significant and
selective reduction of the cellular hPAF1 level relative to the
(unaltered) levels of Pol II and SII (Figure 6D), as well as a
concomitant decrease in the level of p21 transcripts (Figure 6E).
As expected, the ChIP analysis (Figure 6F) revealed a near
complete loss of hPAF1 occupancy on the p21 gene in response
to hPAF1 depletion. In contrast, but with the exception of a
decreased occupancy in the promoter region (C) at the fully
induced (12 hr) stage that accords with the markedly decreased
level of transcription at this time point (Figure 6E), hPAF1 deple-
tion had essentially no effect on either the distribution or density
of Pol II along the p21 gene. This is consistent with results of
similar studies in Drosophila (Adelman et al., 2006) and yeast
(Mueller et al., 2004). Importantly, however, the hPAF1-deficient
cells showed decreased levels of SII at the promoter (C) and
early transcribing (D) regions, supporting our in vitro observation
that hPAF1C enhances and/or stabilizes the interaction of SII
with Pol II.
DISCUSSION
Although several factors have been implicated by genetic anal-
yses in transcription elongation, only a few have been shown
to act directly to facilitate transcription elongation of Pol II on
natural (chromatin) templates. Here, our ability to reconstitute a
recombinant hPAF1C and the availability of a biochemically
defined chromatin-templated assay has allowed us to assess
direct functions of hPAF1C. Our results show, first, that hPAF1C
can act in conjunction with histone acetyltransferase p300, at the
transcription elongation step, to facilitate activator-dependentCell 140, 491transcription from chromatin templates and,
second, that hPAF1C also functions coopera-
tively with SII in this process. Of special note,
these results reflect activities distinct from the
earlier described histone ubiquitylation- andmethylation-dependent chromatin transcription activities of
hPAF1C. From a mechanistic viewpoint, the intrinsic activity of
hPAF1C was shown to depend on subunits that interact with
Pol II and the synergistic activity with SII was shown to involve
a direct interaction with SII that leads to cooperative binding of
SII and hPAF1C to Pol II for facilitation of their intrinsic activities
(Figure 7). By identification of additional, direct hPAF1C func-
tions in transcription and by elaborating mechanistic aspects
of both independent and cooperative functions with SII, our
results expand our understanding of the increasingly complex
transcription elongation process and present additional views
both of individual elongation factor functions and of direct
cross-talk between elongation factors.
Structural Organization of hPAF1C and Specific
Subunit Functions
An analysis of intracellular interactions of combinations of
hPAF1C subunits has led to a model, emphasizing a complex
network of interactions, for the structural organization of hPAF1C
(Figure 1E). hPAF1 and hCTR9 are shown to play key roles as
scaffold proteins, in agreement with yPAF1 complex studies
showing that loss of either yPAF1 or yCTR9 results in nearly
identical severe phenotypes related to many different cellular
processes (Betz et al., 2002; Mueller and Jaehning, 2002). In
addition, we also found that hCTR9 is essential for physical
association of human-specific PAF1C subunit hSKI8 (Figure S2).
Although the five integral subunits of the yeast Paf1C are phy-
logenetically conserved, recent studies of human andDrosophila
PAF1Cs failed to see an association of RTF1 (Rozenblatt-Rosen
et al., 2005; Yart et al., 2005; Zhu et al., 2005; Adelman et al.,
2006). However, our current demonstration of a metastable
association of a short form of hRTF1 with the natural hPAF1C,
as well as the ability to reconstitute a stable hRTF1-containing
six-subunit hPAF1C in insect cells, argue strongly for hRTF1
function within hPAF1C. This notion is further supported by
colocalization of Drosophila (Adelman et al., 2006) and human
(this study) RTF1 with other PAF1 subunits on active genes
and by the demonstration that Drosophila (Adelman et al., 2006;–503, February 19, 2010 ª2010 Elsevier Inc. 499
Tenney et al., 2006) and human (J.K., and R.G.R., unpublished
data) RTF1, like yeast RTF1, are critical for H2B ubiquitylation
and H3K4 methylation. The loss of RTF1 causes relatively subtle
phenotypes in yeast compared to the loss of other subunits such
as PAF1 and CTR9 (Mueller and Jaehning, 2002), thus indicating
more restricted functions for RTF1 as well as PAF1C functions
beyond accessory roles in H2B ubiquitylation and H3 methyla-
tion. Consistent with these observations, and importantly, our
demonstrated roles for hPAF1C in transcription from chromatin
templates were found to be independent of hRTF1 but depen-
dent on two subunits, hPAF1 and hLEO1, that interact directly
with Pol II and SII. Importantly, however, whereas hLEO1 and
hPAF1 are both critical for the cooperative binding of hPAF1C
and SII to Pol II, only hPAF1 (and not hLEO1) is necessary for
the SII-independent binding of hPAF1C to Pol II. Further empha-
sizing subunit-specific functions, LEO1 was earlier shown to be
unimportant for H2B ubiquitylation and H3K4 methylation (Xiao
et al., 2005). These observations indicate distinct roles for
specific subunits in the multi-functional PAF1C (e.g., LEO1 for
transcription; RTF1 for histone modifications; PAF1 for both).
In contrast to our identification of hPAF1 as the dominant Pol
II-binding subunit, CDC73was shown to directly interact with Pol
II in yeast (Shi et al., 1997). Although this may simply reflect
distinct subunit functions in different organisms, we do not
exclude the possibility of a functional hCDC73-Pol II interaction
in human cells. This is plausible since hPAF1C shows a much
stronger interaction with Pol II than do individual hPAF1 or
hLEO1 subunits (Figure 4), implying that cooperative interactions
between hPAF1C subunits (including hCDC73) result in
enhanced binding of the complex to Pol II.
Direct Functions of hPAF1C in Transcription Elongation
The importance of proving direct transcription elongation capa-
bilities is that the presumptive functions in transcription elonga-
tion of factors identified by genetic studies may reflect indirect
effects on transcription elongation. In the case of PAF1C, its
presumed role in transcription elongation is based both on its
occupancy of promoter and transcribed regions (Pokholok
et al., 2002) and on a demonstrated role in H2B ubiquitylation
and H3 methylation events that are dependent on ongoing tran-
scription (Osley, 2004; Kim et al., 2005; Xiao et al., 2005).
However, and especially in view of the diverse PAF1C functions
indicated by genetic analyses (Introduction), it has been unclear
whether PAF1C itself has a more direct function(s) in transcrip-
tion elongation. Related to this important issue, the present
study has clearly shown that hPAF1C has an activity–an intrinsic
ability to directly facilitate transcription elongation from chro-
matin templates–that is clearly distinct from, and independent
of, previously described indirect functions in histone modifica-
tions (Ng et al., 2003; Krogan et al., 2003; Wood et al., 2003;
Zhu et al., 2005). This activity was further shown to be dependent
upon an activator and p300 and to act during transcription elon-
gation rather than PIC formation, consistent with the possibility
that it might somehow be involved in nucleosomal disassembly
and/or displacement in conjunction with p300-mediated histone
acetylation, the ATP-dependent remodeling activity by ACF, and
the histone chaperone activity of NAP1 (all of which are present
in the assay). Although hPAF1C alone shows a chromatin tran-500 Cell 140, 491–503, February 19, 2010 ª2010 Elsevier Inc.scription activity that is reminiscent of that seen with SII alone,
these two factors do exhibit important qualitative functional
differences (M.G. and R.G.R., unpublished observations).
Of note, our current demonstration of a direct function of
hPAF1C in transcription elongation and our recent demonstra-
tion of hPAF1C-dependent transcription-coupled H2B ubiquity-
lation involving a direct interaction between hPAF1 and hBRE1
complexes (Kim et al., 2009) also provide amechanistic explana-
tion for the role of PAF1C in H2B ubiquitylation. Thus, it is
plausible that PAF1C-enhanced passage of Pol II through nucle-
osomes, whether directly or through enhanced SII recruitment
(below), allows H2B ubiquitylation factors (recruited by PAF1C)
easier access to the H2B ubiquitylation site. These results pro-
vide ultimate explanations for how PAF1C links transcription
and H2B ubiquitylation machineries, why PAF1C is required for
H2B ubiquitylation and why H2B ubiquitylation and H3K4/
H3K79 methylation are concentrated on actively transcribing
genes.
Cooperative Functions between Transcription
Elongation Factors
Transcription by Pol II is much more efficient within intact cells,
where various nucleosomal and higher order chromatin
constraints are imposed, than in established in vitro transcription
assays. This suggests a possible need for extensive synergy
in vivo between transcription factors that might include cooper-
ative functions of distinct transcription elongation factors.
Supporting this idea, the present study provides a clear demon-
stration of synergy between two distinct elongation factors,
hPAF1C and SII, in chromatin transcription. Toward an under-
standing of the underlying mechanism, we demonstrate, first,
that the synergistic effect of hPAF1C is greater at sub-saturating
levels of SII and, second, that there is a direct interaction
between SII and hPAF1C (through the hPAF1 and hLEO1
subunits) that results in cooperative binding to Pol II and is
required for their full synergistic function. The latter conclusion
is strongly supported by the observation, mentioned above,
that hLEO1, in contrast to hPAF1, is selectively required for the
cooperative binding of hPAF1C and SII to Pol II and not for the
SII-independent binding of hPAF1C to Pol II. Hence, one mech-
anism of action of hPAF1C, beyond that involved in SII-indepen-
dent elongation (above), is to facilitate SII recruitment and/or
stabilization for its previously established role in Pol II passage
through nucleosomes (Kireeva et al., 2005; Guermah et al.,
2006). The relevance of such a cooperative and possibly redun-
dant mechanism is strengthened by the fact that simultaneous
mutation of PAF1 and DST1 is lethal in yeast (Squazzo et al.,
2002).
Despite their strong physical interaction and functional coop-
erativity in transcription elongation, hPAF1C and SII show
non-identical (but overlapping) patterns of occupancy on the
p21 gene (Figure 6). This is entirely consistent with the likelihood
that these transcription elongation factors have both distinct and
coupled functions/mechanisms in transcription. As described
below, PAF1C participates in multiple transcription-related
processes (initiation, elongation, mRNA processing and histone
modifications) that may involve differential localization and/or
stabilization of PAF1C on regions extending from the promoter
to the 30 end of gene. Hence, the overall PAF1C ChIP pattern
represents the sum of the individual patterns for the different
PAF1C functions, and any single strong process, such as the
PAF1C-dependent H2B ubiquitylation that peaks with PAF1C
subunits downstream of SII and Pol II (Kim et al., 2005), may
bias the distribution. Nonidentical ChIP patterns are also evident
for other interacting factors. Thus, despite established physical
interactions of PAF1C with DSIF (Qiu et al., 2006) and FACT
(Squazzo et al., 2002), PAF1C shows a ChIP pattern clearly
distinct from those of DISF (Qiu et al., 2006) and FACT (cf.
Figure 6 and Gomes et al., 2007). These considerations suggest
that physical interactions and resulting cooperative functions of
distinct transcription elongation factors do not necessitate their
exact colocalization on actively transcribed target genes.
The presence of multiple elongation factors and their genetic
and physical interactions strongly suggests a complex network
of communications and cooperative functions between elonga-
tion factors during transcriptional control in eukaryotic cells.
The present study, employing a defined assay system, sets the
stage for subsequent studies of detailed functional and mecha-
nistic aspects of transcription elongation factors, including their
communication with gene-specific activators and components
of the transcription and chromatin-modifying machineries. This
is especially important for the PAF1 complex, with its expanding
and, in some cases, gene-specific roles in various physiological
processes (Introduction).Possible Roles of hPAF1C at Distinct Stages
of Transcription
Besides the PAF1C transcription elongation functions empha-
sized in this study, functions in other transcription-related
processes (Introduction), including transcription initiation, have
also been suggested. Thus, genetic studies in yeast have sug-
gested key roles for PAF1C in TATA site selection (Stolinski
et al., 1997; Mueller and Jaehning, 2002) and in communication
with DNA-binding factors (Betz et al., 2002), whereas studies in
metazoans have shown direct interactions with transcriptional
activators (Mosimann et al., 2006; Youn et al., 2007). In further
support of these observations, we also found that hPAF1C (1)
interacts directly with p53 both in vitro and in vivo, (2) increases
transcription from histone-free DNA templates, where the elon-
gation process in the purified system is not a major rate-limiting
step and (3) slightly stimulates the generation of short transcripts
from a chromatin template (J.K. and R.G.R., unpublished data).
These results indicate a possible role for hPAF1C at an initiation
and/or an early post-initiation step in transcription and support
the view that PAF1C is involved in multiple processes in tran-
scriptional regulation. Related to this, the decreased transcrip-
tion of specific genes that is observed in PAF1-deficient cells
(Figure 6; Adelman et al., 2006; Ding et al., 2009) is potentially
due to a combined effect of defects in several PAF1C functions
in transcription.EXPERIMENTAL PROCEDURES
Cell Lines, Nuclear Extracts, and Native hPAF1C Purification
The FLAG-hPAF1 cell line was selected from HeLa S3 cells transfected with
a FLAG-hPAF1-pCDNA3 plasmid. Derived nuclear extracts (Dignam et al.,1983), were incubated with M2 agarose in BC buffer (20 mM Tris [pH 7.9],
0.2 mM EDTA, 20% glycerol) containing 300 mM KCl (BC300; hereafter, the
number indicates the KCl concentration added to the BC buffer) and 0.1%
NP40 at 4C for 4 hr. After extensive washing with BC300/0.1% NP40, bound
hPAF1C was eluted with 0.3 mg/ml FLAG peptide in BC200/0.02% NP40.
Reconstitution of hPAF1C
cDNAs for hCTR9 (Genebank accession number: BC058914), hLEO1
(BC018147), hPAF1 (AJ401156), hCDC73 (NM_024529), hRTF1 (BC015052)
and hSKI8 (AK024754) were obtained from ATCC and subcloned into pFAST-
BAC1 vector with or without the N-terminal FLAG epitope. Corresponding
baculoviruses were generated according to the manufacturer’s instruction
(GIBCO-Invitrogen). Sf9 cells were infected with combinations of baculovi-
ruses and proteins/complexes were affinity purified on M2 agarose (Kim
et al., 2009).
Protein Interaction Assays
For assays with M2 agarose-immobilized proteins, reactions contained (i)
reconstituted hPAF1Cs (5 mg for the intact complex) containing equivalent
amounts of FLAG-hCTR9 and 750 ng purified native (untagged) Pol II (Fig-
ure 4A), (ii) 2 mg of individual purified FLAG-tagged hPAF1C subunits and
1 mg HeLa nuclear extract (Figure 4B) or (iii) 5 mg of purified FLAG-hPAF1C,
1 mg HeLa nuclear extract and 2 mg of purified SII (Figure 5A, right panel).
The general conditions for binding and washing were BC200/0.05%NP40.
Bound proteins were analyzed by immunoblot with indicated antibodies.
GST-pull down and coimmunoprecipitation assays were performed as
described (Kim et al., 2005).
RT-PCR Assays
Total RNA was prepared using Trizol (GIBCO-Invitrogen) and RT-PCR
analyses were performed. Primers for conventional (Figure 6A) and quantita-
tive (Figure 6E) PCR reactions are summarized in Table S1 and Table S2,
respectively.
Chromatin Immunoprecipitation Assays
HCT116 cells grown in McCoy’s 5A (GIBCO-Invitrogen) were treated with
0.5 mM doxorubicin (Sigma) for the indicated times. ChIP analyses were per-
formed according to the manufacturer’s instructions (Upstate). Primers for
quantitative PCR are summarized in Table S3. For the RNAi-coupled ChIP
analyses in Figure 6F, HCT116 cells were treated for 48 hr with siRNA duplexes
(Dharmacon) using oligofectamine (GIBCO-Invitrogen) and then subjected to
ChIP analyses as described above.
Chromatin Assembly and In Vitro Transcription
Detailed protocols are described in Extended Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and three tables and can be found with this article online at
doi:10.1016/j.cell.2009.12.050.
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